GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Opilon® | thymoxamine
moxisylyte is an approved drug
Compound class:
Synthetic organic
Comment: Moxisylyte is an antagonist of α1 adrenoceptors, with some selectivity for the α1A subtype [2]. It improves blood circulation to the extremities and has been used to treat primary Raynaud's syndrome .
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 1538 | moxisylyte |
Synonyms ![]() |
| Opilon® | thymoxamine |
Database Links ![]() |
|
| GtoPdb PubChem SID | 479821097 |
| PubChem CID | 4260 |
| Search Google for chemical match using the InChIKey | VRYMTAVOXVTQEF-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | VRYMTAVOXVTQEF |
| Search PubMed clinical trials | moxisylyte |
| Search PubMed titles | moxisylyte |
| Search PubMed titles/abstracts | moxisylyte |
| UniChem Compound Search for chemical match using the InChIKey | VRYMTAVOXVTQEF-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | VRYMTAVOXVTQEF-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖